Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
Li C, Xu J, Luo W, Liao D, Xie W, Wei Q, Zhang Y, Wang X, Wu Z, Kang Y, Zheng J, Xiong W, Deng J, Hu Y, Mei H.
Li C, et al. Among authors: xie w.
Leukemia. 2024 Jan;38(1):149-159. doi: 10.1038/s41375-023-02065-x. Epub 2023 Oct 17.
Leukemia. 2024.
PMID: 37848634
Free PMC article.